Lucid Diagnostics (LUCD) Current Leases (2022 - 2026)
Lucid Diagnostics (LUCD) posted Current Leases of $908000.0 for Q1 2026, up 1.68% on a QoQ basis from $893000.0 in Q4 2025, and up 4.73% year-over-year from $867000.0 in Q1 2025.
Lucid Diagnostics (LUCD) Current Leases (2022 - 2026) Analysis & Trends
Lucid Diagnostics' Current Leases history runs 5 years deep, the most recent figure standing at $908000.0 for Q1 2026.
- Quarterly Current Leases rose 4.73% year-over-year to $908000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $908000.0 (up 4.73% YoY) and the FY2025 annual result came in at $893000.0, up 4.57% from the prior year.
- Current Leases was $908000.0 for Q1 2026 at Lucid Diagnostics, up from $893000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.1 million in Q3 2023 and bottomed at $769000.0 in Q1 2022.
- A 5-year average of $920235.3 and a median of $878000.0 in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases jumped 37.72% — and 2024, when it fell 24.2%.
- Lucid Diagnostics' Current Leases stood at $962000.0 in 2022, then climbed by 14.97% to $1.1 million in 2023, then decreased by 22.78% to $854000.0 in 2024, then grew by 4.57% to $893000.0 in 2025, then advanced by 1.68% to $908000.0 in 2026.
- Business Quant data shows LUCD's Current Leases at $908000.0 in Q1 2026, $893000.0 in Q4 2025, and $878000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | 908,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 908,000.00 |
| Dec 31, 2025 | 893,000.00 |
| Sep 30, 2025 | 878,000.00 |
| Jun 30, 2025 | 871,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Dec 31, 2024 | 854,000.00 |
| Sep 30, 2024 | 855,000.00 |
| Jun 30, 2024 | 884,000.00 |
| Mar 31, 2024 | 861,000.00 |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.05 Mn |
| Dec 31, 2022 | 962,000.00 |
| Sep 30, 2022 | 860,000.00 |
| Jun 30, 2022 | 798,000.00 |
| Mar 31, 2022 | 769,000.00 |